A Growing Specialty Pharmaceutical Company
Impax Laboratories, Inc. (NASDAQ: IPXL) is a company of exceptional people, impressive achievements and exciting potential. Founded in 1995, Impax has since evolved to become a growing specialty pharmaceutical company. Today, we provide access to affordable, high-quality generics and specialty pharmaceutical products across the U.S.
Impax serves patients through two key divisions. Our Generics business offers an established and growing portfolio of generic pharmaceuticals. Our Specialty Pharma business brings new medicines to market in central nervous system disorders, parasitic infections and other therapeutic categories.
Our continued growth is focused on four key pillars known as Our “Path Forward,” and includes:
- Invest For Growth – continue to expand and diversify our portfolios in Generics and Specialty Pharma
- Maintain Customer Focus – continue to deliver high quality products and service to our customers
- Align for Growth – continue to align our infrastructure, enhance profitability and provide additional resources to support short- and long-term growth
- Pursue Creative Business Development – identify potential partnerships and/or merger and acquisition opportunities to enhance the depth and breadth of our business
Beyond our commitment to delivering high-quality products for our customers and value for our shareholders, we also believe in being a good corporate citizen. Our efforts in corporate responsibility include philanthropic donations, volunteerism, sustainable business practices and support for advocacy programs. Across our company, many employees are actively engaged and take pride in supporting important initiatives that provide an opportunity to give back within the communities where they live and work.